PMC:7784830 / 24092-24224
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 402 | 14-46 | Disease | denotes | Middle East Respiratory Syndrome | MESH:D018352 |
| 403 | 48-52 | Disease | denotes | MERS | MESH:D018352 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T191 | 0-132 | Sentence | denotes | Novavax, Inc Middle East Respiratory Syndrome (MERS) vaccine was developed using recombinant nanoparticle based vaccine technology. |